A new review on the impact of the microbiome in the upper airways on URTIs entitled, “…
Ana Pamplona, PhD
Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pamplona, PhD
A new study entitled “Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care…
Lung transplantation patients who are treated with immune-suppressing drugs after surgery to prevent rejection of the lung are susceptible…
The rise in bacterial strains that are highly resistant to antibiotics is a growing health concern, as the research…
A new Cystic Fibrosis study entitled “Early Respiratory Infection Is Associated with Reduced Spirometry in Children…
New research on the mechanism of infection of the bacteria Pseudomonas aeruginosa entitled “Surface attachment induces…
A major breakthrough in the understanding of respiratory diseases entitled “The draft genome sequence of the…
Proteostasis Therapeutics, a company developing novel therapeutics for Cystic Fibrosis and other diseases to address defects in protein folding,…
A recent study entitled “Stochastic Tracking of Infection in a CF Lung” presents a new algorithm that improves…
A new study on the impact of Cystic Fibrosis carrier status in in vitro fertilization (IVF) procedures and outcomes,…